Financial incentives for hypertension control: rationale and study design

Table 1 Data collection schedule

Items	Baseline 1	Baseline 2	Follow-up time (months)
Items	Baseline 1	Baseline 2	1	3	6	12(1)	12(2)
Informed consent	×
Inclusion and exclusion process	×	×
Physical examination	×		×	×	×	×
Lifestyle	×		×	×	×	×
History of disease	×
Cognitive status	×						×
Blood pressure	×	×	×	×	×	×	×
Medications use	×		×	×	×	×
Blood and urine examination		×					×
Atherosclerosis tests		×					×
Incident CVD events			×	×	×	×

Baseline 1 and Baseline 2 represent the first and second day of the baseline survey, respectively
12 (1) and 12 (2) represents the first and second day of follow-up months 12
CVD cardiovascular disease

ISSN: 1745-6215